Harrow, Inc. (NASDAQ:HROW) Shares Purchased by Neuberger Berman Group LLC

Neuberger Berman Group LLC increased its holdings in Harrow, Inc. (NASDAQ:HROW - Free Report) by 128.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 200,529 shares of the company's stock after buying an additional 112,588 shares during the period. Neuberger Berman Group LLC owned about 0.56% of Harrow worth $6,728,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in HROW. AlphaQuest LLC lifted its stake in shares of Harrow by 452.8% during the 4th quarter. AlphaQuest LLC now owns 3,527 shares of the company's stock worth $118,000 after purchasing an additional 2,889 shares during the period. Federated Hermes Inc. acquired a new position in shares of Harrow during the 4th quarter valued at about $214,000. Maridea Wealth Management LLC purchased a new position in shares of Harrow during the 4th quarter worth about $222,000. KLP Kapitalforvaltning AS acquired a new position in Harrow during the fourth quarter worth approximately $235,000. Finally, China Universal Asset Management Co. Ltd. raised its stake in Harrow by 10.7% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 7,552 shares of the company's stock worth $253,000 after purchasing an additional 727 shares during the period. 72.76% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

HROW has been the subject of a number of research reports. B. Riley lowered their price target on Harrow from $69.00 to $65.00 and set a "buy" rating for the company in a research report on Tuesday, April 1st. HC Wainwright restated a "buy" rating and issued a $57.00 price target on shares of Harrow in a report on Monday, March 31st.

Harrow Stock Up 1.5 %

Shares of NASDAQ:HROW traded up $0.35 during midday trading on Thursday, reaching $23.70. The company had a trading volume of 72,854 shares, compared to its average volume of 506,781. The stock has a market capitalization of $845.11 million, a P/E ratio of -25.29 and a beta of 0.46. The stock's fifty day moving average price is $26.44 and its 200-day moving average price is $35.99. The company has a debt-to-equity ratio of 3.23, a current ratio of 1.55 and a quick ratio of 1.44. Harrow, Inc. has a one year low of $9.86 and a one year high of $59.23.

Harrow (NASDAQ:HROW - Get Free Report) last announced its quarterly earnings data on Thursday, March 27th. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.14. Harrow had a negative return on equity of 45.57% and a negative net margin of 19.75%. The firm had revenue of $66.83 million during the quarter, compared to analyst estimates of $66.01 million. Equities research analysts expect that Harrow, Inc. will post -0.53 earnings per share for the current fiscal year.

Harrow Profile

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.